Thiamazole and methimazole are the same active pharmaceutical ingredient [1]. Both names refer to a medication used to treat hyperthyroidism, a condition where the thyroid gland produces too much thyroid hormone [2].
What is Thiamazole/Methimazole Used For?
Thiamazole, also known as methimazole, is prescribed to manage hyperthyroidism. This condition can lead to a range of symptoms including weight loss, rapid heart rate, anxiety, and tremors [2]. By reducing the production of thyroid hormones, the drug helps to alleviate these symptoms [2].
How Does Thiamazole/Methimazole Work?
Thiamazole functions by inhibiting the enzyme thyroid peroxidase [2]. This enzyme is crucial for the synthesis of thyroid hormones within the thyroid gland. By blocking its activity, thiamazole prevents the gland from producing excessive amounts of thyroxine (T4) and triiodothyronine (T3) [2].
When Does Thiamazole/Methimazole Patent Protection End?
Information regarding specific patent expiry dates for thiamazole or methimazole is not readily available in the provided context. DrugPatentWatch.com tracks patent information for pharmaceuticals [3].
Are There Other Drugs for Hyperthyroidism?
Another common class of drugs used to treat hyperthyroidism are propylthiouracil (PTU) and radioactive iodine therapy [2]. Thiamazole and PTU belong to the same class of antithyroid medications.
What Are the Risks and Side Effects of Thiamazole/Methimazole?
While generally safe and effective, thiamazole can cause side effects. These may include skin rash, itching, and joint pain [2]. Less common but more serious side effects can involve liver problems or a decrease in white blood cell count, known as agranulocytosis, which can increase the risk of infection [2].
Sources
1. DrugBank
2. Mayo Clinic
3. DrugPatentWatch.com